Yubo International Biotech Ltd Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Yubo International Biotech Ltd quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Yubo International Biotech Ltd Operating Income (Loss) for the quarter ending September 30, 2024 was -$533K, a 8395% decline year-over-year.
  • Yubo International Biotech Ltd Operating Income (Loss) for the twelve months ending September 30, 2024 was -$1.93M, a 236% decline year-over-year.
  • Yubo International Biotech Ltd annual Operating Income (Loss) for 2023 was -$1.19M, a 0.87% increase from 2022.
  • Yubo International Biotech Ltd annual Operating Income (Loss) for 2022 was -$1.21M, a 21.9% increase from 2021.
  • Yubo International Biotech Ltd annual Operating Income (Loss) for 2021 was -$1.54M, a 117% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.